Skip to main content
Premium Trial:

Request an Annual Quote

Lab21 to Offer Saladax Chemotherapy Management Tests

NEW YORK (GenomeWeb News) – Saladax Biomedical today said that Lab21 will offer the firm's Personalized Chemotherapy Management assays as a service offering in the UK, Ireland, and Middle East, under a distribution agreement between the firms.

Bethlehem, Pa.-based Saladax said that Lab21 is the first clinical reference lab to offer testing services based on the firm's 5-fluorouracil PCM reagent kits. Cambridge, UK-based Lab21 will market the dose-management service under the trade name DoseCheck.

Berwyn Clarke, chief scientific and development officer for Lab21, said in a statement that the test "will provide higher physician confidence in dosing this widely used drug and will provide patients with the potential of longer survival with a better quality of life while undergoing treatment."

Filed under

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.